Advertisement

Topics

Accent Therapeutics Company Profile

18:26 EDT 19th October 2018 | BioPortfolio

Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of epitranscriptomics. This field of biology encompasses post-transcriptional chemical modifications of RNA that provide cells with a unique mechanism for regulating proteins critical for cellular growth and differentiation. By targeting cancer-linked RNA-modifying proteins (RMPs) with precision therapies, we aim to translate extraordinary science into life-changing therapies for patients. For more information, please visit www.accenttx.com.


News Articles [777 Associated News Articles listed on BioPortfolio]

Accent Therapeutics Launches with $40 Million: Focus on RNA-Modifying Proteins

Accent Therapeutics, headquartered in Cambridge, Massachusetts, closed on a $40 million Series A financing. Accent will focus on the fairly new area of epitranscriptomics.

Biopharmaceutical firm Accent Therapeutics launches with $40m financing

Accent Therapeutics has been launched with $40m Series A financing for precision cancer treatments targeting RNA-modifying proteins.

Accent Therapeutics gains $40M from funding round

A Series A financing round raised $40 million for Accent Therapeutics, which is developing gene regulation technologies targe -More- 

Accent on RNA

Accent Therapeutics debuts with a $40 million series A to develop small molecule inhibitors of RNA-modifying proteins to treat cancer.

Confident Tone Overcomes Accent Distrust

English as-a-first-language Canadian study subjects were less trusting of statements in English spoken with a foreign accent, unless the speaker sounded confident about their assertion. -- Read mo...

Do we trust people who speak with an accent?

(McGill University) A recently published study shows that unless they speak in a confident tone of voice, you're less likely to believe someone who speaks with an accent. And, interestingly, as you ma...

Accent Therapeutics launches with $40 million Series A round

Company will pursue RNA-modifying protein targets to discover and develop new treatments in oncology.

A Liberal accent: Linguistics team documents language changes in southwest Kansas

A linguistics team has found that people in southwest Kansas are developing a distinct accent.

PubMed Articles [457 Associated PubMed Articles listed on BioPortfolio]

The impact of foreign accent on irony interpretation.

In modern multi-cultural societies, conversations between foreign speakers and native listeners have become very common. These exchanges often include the use of figurative language. The present study...

And then I saw her race: Race-based expectations affect infants' word processing.

How do our expectations about speakers shape speech perception? Adults' speech perception is influenced by social properties of the speaker (e.g., race). When in development do these influences begin?...

On the effects of regional accents on memory and credibility.

The information we obtain from how speakers sound-for example their accent-affects how we interpret the messages they convey. A clear example is foreign accented speech, where reduced intelligibility ...

Maintaining information about speech input during accent adaptation.

Speech understanding can be thought of as inferring progressively more abstract representations from a rapidly unfolding signal. One common view of this process holds that lower-level information is d...

Regularity and dimensional salience in temporal grouping.

How do pitch and duration accents combine to influence the perceived grouping of musical sequences? Sequence context influences the relative importance of these accents; for example, the presence of l...

Clinical Trials [163 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Optimal Sensing in Atrial Tachyarrhythmia's Study

The aim of the study is the comparison of two different leads in their capabilities to detect episodes and duration of paroxysmal atrial fibrillation (AF) and atrial tachyarrhythmia (AT), ...

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1268 Associated Companies listed on BioPortfolio]

Accent Therapeutics

Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of epitranscriptomics. This field of biology encompa...

Accent on Aesthetics Plastic Surgery Medical Center

As Medical Director of Accent on Aesthetics Plastic Surgery Medical Center, Dr. Howard L. Rosenberg is one of the Bay Area's most sought-after experts on cosmetic enhancement. With over two decades of...

Accent on Integration

Accent on Integration (AOI) enables data sharing by interconnecting healthcare organizations’ disparate technology systems and medical devices using its portfolio of vendor-a...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

More Information about "Accent Therapeutics" on BioPortfolio

We have published hundreds of Accent Therapeutics news stories on BioPortfolio along with dozens of Accent Therapeutics Clinical Trials and PubMed Articles about Accent Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Accent Therapeutics Companies in our database. You can also find out about relevant Accent Therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record